$172.51
+1.05
(+0.61%)▲
1.52%
Downside
Day's Volatility :1.56%
Upside
0.03%
32.27%
Downside
52 Weeks Volatility :37.19%
Upside
7.27%
Period | Balchem Corp | Sector (Materials) | Index (Russel 2000) |
---|---|---|---|
3 Months | 5.02% | 6.3% | 0.0% |
6 Months | 12.52% | 4.5% | 0.0% |
1 Year | 42.72% | 18.7% | 0.0% |
3 Years | 6.58% | 6.5% | -27.4% |
Market Capitalization | 5.6B |
Book Value | $36.21 |
Dividend Share | 0.79 |
Dividend Yield | 0.46% |
Earnings Per Share (EPS) | 3.74 |
PE Ratio | 45.84 |
PEG Ratio | 4.64 |
Wall Street Target Price | 188.67 |
Profit Margin | 12.9% |
Operating Margin TTM | 20.22% |
Return On Assets TTM | 6.42% |
Return On Equity TTM | 11.04% |
Revenue TTM | 942.4M |
Revenue Per Share TTM | 29.21 |
Quarterly Revenue Growth YOY | 4.3% |
Gross Profit TTM | 280.5M |
EBITDA | 215.1M |
Diluted Eps TTM | 3.74 |
Quarterly Earnings Growth YOY | 0.14 |
EPS Estimate Current Year | 4.35 |
EPS Estimate Next Year | 4.88 |
EPS Estimate Current Quarter | 1.11 |
EPS Estimate Next Quarter | 1.14 |
What analysts predicted
Upside of 9.37%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 643.7M | ↑ 8.22% |
Net Income | 78.6M | ↓ 12.77% |
Net Profit Margin | 12.21% | ↓ 2.93% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 643.7M | ↑ 0.0% |
Net Income | 79.7M | ↑ 1.4% |
Net Profit Margin | 12.38% | ↑ 0.17% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 703.6M | ↑ 9.31% |
Net Income | 84.6M | ↑ 6.22% |
Net Profit Margin | 12.03% | ↓ 0.35% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 799.0M | ↑ 13.56% |
Net Income | 96.1M | ↑ 13.57% |
Net Profit Margin | 12.03% | ↑ 0.0% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 942.4M | ↑ 17.94% |
Net Income | 105.4M | ↑ 9.64% |
Net Profit Margin | 11.18% | ↓ 0.85% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 922.4M | ↓ 2.11% |
Net Income | 108.5M | ↑ 3.01% |
Net Profit Margin | 11.77% | ↑ 0.59% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 231.3M | ↓ 0.55% |
Net Income | 30.1M | ↑ 32.58% |
Net Profit Margin | 13.02% | ↑ 3.25% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 229.9M | ↓ 0.56% |
Net Income | 29.1M | ↓ 3.44% |
Net Profit Margin | 12.64% | ↓ 0.38% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 228.7M | ↓ 0.54% |
Net Income | 26.6M | ↓ 8.35% |
Net Profit Margin | 11.65% | ↓ 0.99% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 239.7M | ↑ 4.79% |
Net Income | 29.0M | ↑ 8.77% |
Net Profit Margin | 12.09% | ↑ 0.44% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 234.1M | ↓ 2.33% |
Net Income | 32.1M | ↑ 10.64% |
Net Profit Margin | 13.7% | ↑ 1.61% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Revenue | 239.9M | ↑ 2.5% |
Net Income | 33.8M | ↑ 5.51% |
Net Profit Margin | 14.1% | ↑ 0.4% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 981.4M | ↑ 1.84% |
Total Liabilities | 289.7M | ↓ 16.44% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 1.2B | ↑ 17.76% |
Total Liabilities | 412.0M | ↑ 42.2% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.2B | ↑ 0.88% |
Total Liabilities | 337.6M | ↓ 18.06% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.2B | ↑ 2.87% |
Total Liabilities | 322.3M | ↓ 4.53% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | ↑ 35.45% |
Total Liabilities | 686.2M | ↑ 112.91% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | ↑ 0.04% |
Total Liabilities | 571.2M | ↓ 16.77% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↓ 0.59% |
Total Liabilities | 612.3M | ↓ 6.56% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↓ 0.97% |
Total Liabilities | 578.2M | ↓ 5.57% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↑ 1.35% |
Total Liabilities | 571.2M | ↓ 1.22% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↓ 2.24% |
Total Liabilities | 509.9M | ↓ 10.72% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↓ 0.86% |
Total Liabilities | 462.6M | ↓ 9.28% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↑ 1.4% |
Total Liabilities | 419.7M | ↓ 9.27% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 118.7M | ↑ 7.3% |
Investing Cash Flow | -32.0M | ↓ 25.07% |
Financing Cash Flow | -71.4M | ↑ 4.11% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 124.5M | ↑ 4.86% |
Investing Cash Flow | -156.2M | ↑ 388.34% |
Financing Cash Flow | 43.4M | ↓ 160.72% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 150.5M | ↑ 20.92% |
Investing Cash Flow | -34.6M | ↓ 77.86% |
Financing Cash Flow | -101.2M | ↓ 333.18% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 160.5M | ↑ 6.66% |
Investing Cash Flow | -35.3M | ↑ 2.05% |
Financing Cash Flow | -102.2M | ↑ 1.0% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 138.5M | ↓ 13.69% |
Investing Cash Flow | -416.0M | ↑ 1078.51% |
Financing Cash Flow | 246.7M | ↓ 341.42% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 35.0M | ↑ 0.44% |
Investing Cash Flow | -3.6M | ↓ 64.11% |
Financing Cash Flow | -24.8M | ↓ 25.69% |
Sell
Neutral
Buy
Balchem Corp is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Balchem Corp | 1.56% | 12.52% | 42.72% | 6.58% | 71.99% |
Air Products & Chemicals Inc. | -2.11% | 23.62% | 5.08% | -1.04% | 41.33% |
Linde Plc | -1.06% | 7.43% | 16.62% | 38.05% | 128.81% |
Dupont De Nemours Inc | -4.76% | 4.23% | 17.7% | 1.8% | 13.08% |
Sherwin-williams Company, The | 1.8% | 18.86% | 49.46% | 17.36% | 98.83% |
Ecolab Inc. | -1.83% | 6.79% | 40.14% | 5.99% | 26.7% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Balchem Corp | 45.84 | 45.84 | 4.64 | 4.35 | 0.11 | 0.06 | 0.0 | 36.21 |
Air Products & Chemicals Inc. | 26.89 | 26.89 | 1.65 | 12.33 | 0.16 | 0.05 | 0.02 | 67.93 |
Linde Plc | 34.72 | 34.72 | 2.52 | 15.5 | 0.16 | 0.07 | 0.01 | 82.27 |
Dupont De Nemours Inc | 105.77 | 105.77 | 0.46 | 3.77 | 0.01 | 0.03 | 0.02 | 55.9 |
Sherwin-williams Company, The | 35.58 | 35.58 | 3.33 | 11.31 | 0.64 | 0.1 | 0.01 | 16.59 |
Ecolab Inc. | 34.25 | 34.25 | 2.45 | 6.65 | 0.25 | 0.07 | 0.01 | 23.46 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Balchem Corp | Buy | $5.6B | 71.99% | 45.84 | 12.9% |
Air Products & Chemicals Inc. | Buy | $68.7B | 41.33% | 26.89 | 21.24% |
Linde Plc | Buy | $217.8B | 128.81% | 34.72 | 19.33% |
Dupont De Nemours Inc | Buy | $34.4B | 13.08% | 105.77 | 5.51% |
Sherwin-williams Company, The | Buy | $90.2B | 98.83% | 35.58 | 11.09% |
Ecolab Inc. | Hold | $69.3B | 26.7% | 34.25 | 13.05% |
Insights on Balchem Corp
Revenue is up for the last 2 quarters, 234.08M → 239.94M (in $), with an average increase of 2.4% per quarter
Netprofit is up for the last 4 quarters, 26.64M → 33.83M (in $), with an average increase of 7.6% per quarter
In the last 1 year, Sherwin-williams Company, The has given 49.2% return, outperforming this stock by 6.7%
In the last 3 years, Linde Plc has given 17.4% return, outperforming this stock by 10.8%
BlackRock Inc
Vanguard Group Inc
Apg All Pensions Group
Wasatch Advisors LP
Morgan Stanley - Brokerage Accounts
State Street Corp
founded in 1967, balchem provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. our company consists of four business segments: human nutrition & health; specialty products; animal nutrition and health and industrial products. balchem employs approximately 1,000 people worldwide who are engaged in many diverse activities, developing our company into chosen market leadership positions. visit our website at www.balchem.com to learn more about us and the exciting opportunities we have available!
Organization | Balchem Corp |
Employees | 1300 |
CEO | Mr. Theodore L. Harris |
Industry | Process Industries |
Stericycle, Inc.
$172.51
+0.61%
Sensient Technologies Corp
$172.51
+0.61%
Microstrategy Inc.
$172.51
+0.61%
Clear Secure, Inc.
$172.51
+0.61%
Cg Oncology Inc.
$172.51
+0.61%
Harley-davidson, Inc.
$172.51
+0.61%
Invesco Ultra Short Duration Etf
$172.51
+0.61%
Capital Group Global Growth
$172.51
+0.61%
Ishares Long-term Corporate Bond Etf
$172.51
+0.61%